Euro vs US Dollar

Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

Registrieren

IMMX Immix Biopharma Inc

2,47

0,22 (9,78%)

17 Mai 2024 - Geschlossen

Verzögert um 15 Minuten

Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]

Immix Biopharma (NASDAQ:IMMX)
Historical Stock Chart
Von Apr 2024 bis Mai 2024

Click Here for more Immix Biopharma Charts.

Immix Biopharma (NASDAQ:IMMX)
Historical Stock Chart
Von Mai 2023 bis Mai 2024

Click Here for more Immix Biopharma Charts.

News Immix Biopharma Inc

Form 4 - Statement of changes in beneficial ownership of securities
Mittwoch 15 Mai 2024 (4 Tage vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Mittwoch 15 Mai 2024 (4 Tage vor) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Donnerstag 9 Mai 2024 (1 Woche vor) • Edgar (US Regulatory)

Form 424B5 - Prospectus [Rule 424(b)(5)]
Mittwoch 7 Februar 2024 (3 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Dienstag 6 Februar 2024 (3 Monate vor) • Edgar (US Regulatory)

Form 424B5 - Prospectus [Rule 424(b)(5)]
Montag 5 Februar 2024 (3 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Montag 5 Februar 2024 (3 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Mittwoch 13 Dezember 2023 (5 Monate vor) • Edgar (US Regulatory)

Immix Biopharma Announces FDA Approval of IND Application for CAR-T NXC-201, Enabling U.S. Patient Dosing
Dienstag 28 November 2023 (6 Monate vor) • InvestorsHub NewsWire

Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
Freitag 10 November 2023 (6 Monate vor) • Edgar (US Regulatory)

Form S-3 - Registration statement under Securities Act of 1933
Montag 25 September 2023 (8 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Dienstag 19 September 2023 (8 Monate vor) • Edgar (US Regulatory)

Weitere Immix Biopharma Inc News-Artikel

Walkabout Resources

CLPS Incorporation

Australian Government Tr...

Mechanical Technology

Vontobel Financial Produ...

Spring Valley Acquisitio...

Sandfire Resources NL (PK)

NLBNPIT1ULN9 20351221 14...

Strategic Income Closed ...

Jackpot Digital

Great West Lifeco

Australian Critical Mine...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen